Explore 2025 global clinical trial compliances helping CROs achieve operational excellence with quality, safety, and regulatory efficiency. Abstract The global clinical research landscape in 2025 is undergoing a transformative shift. New regulatory frameworks, such as ICH E6(R3), updated FDA guidance…
Abstract Traditional clinical trials often span years and demand significant financial investment, slowing drug development and delaying patient access to therapies. Novel trial designs Basket Trials, Umbrella Trials, and Platform Trials have emerged as adaptive strategies that enhance efficiency, reduce…
Launching global clinical trials is overwhelming every region demands unique compliance, submissions, and approval timelines. Having worked with diverse regulatory bodies (DCGI, FDA, EMA), we know how critical early readiness is. This guide gives you a clear comparison of India,…
Phase-by-Phase Clinical Trial Costs provides a complete assessment of costs of clinical trials by phase and therapeutic area, with a focus on key cost components including per-patient costs, total costs, contract research organization pricing, and service-specific expenses. Clinical trials represent…
Be the first to know the latest trends in clinical research, real-world case studies, and industry secrets.
ProRelix Research is the rapidly growing Contract/ Clinical Research Organization (CRO) with multi-country service capability supporting phase 1, 2, 3, & 4 clinical trials of Pharma, Biotech, Biopharma, Medical Device, Nutraceutical & Herbal companies to conduct in the USA, India, Europe & South East Asia.